David Stíbal is a Vice Director of the BioTech incubator and venture builder i&i Prague. David completed his bachelor’s and master’s degrees at the University of Chemistry and Technology in Prague, earned a Ph.D. from the University of Neuchâtel in Switzerland, and conducted postdoctoral research at the prestigious Massachusetts Institute of Technology (MIT). At i&i Prague, David focuses on the evaluation of the business potential of scientific projects, establishing and initial management of startups, as well as on the long-term development of projects all the way to their successful commercialization.

i&i Prague focuses on creating innovative BioTech start-ups and spin-offs in the fields of drug development, diagnostics and MedTech and from the region of the Czech Republic, Poland and overall Central Europe. i&i Prague is closely connected to the Institute of Organic Chemistry and Biochemistry in Prague and benefits from its knowhow, network and previous commercialization successes.